Our data suggest that Cep55 overexpression-induced tumorigenesis mimics the tumorigenesis pattern observed in Trp53−/− mice22,23, as it induces a significantly higher percentage of lymphomas (~51%) and sarcomas (~25%) (Fig. 1d). The gene discussed is CEP55; the disease is lymphoma.